Onconetix Corp (ONCO): Net earnings per share (EPS TTM)

ONCO (Onconetix Corporation) - company brandmark

Onconetix, Inc. (ONCO) focuses on men's health, minimizing environmental impact through digitalization and sustainable resource management. The 12-month EPS trend reflects current dynamics, where this metric equals -1984.47. Patents in radiosensitization and strict FDA oversight serve as a defensive moat for the business. However, a high burn rate and the consequences of a profile shift create financial risks regarding the company's viability.

ONCO Onconetix, Inc. Net earnings per share for the last four quarters (02/21/2024 - 11/17/2026)

Financial and market metric breakdowns for Onconetix Corp (ONCO)

- current quotes and average value forecast:
Initial company analysis:ONCO - Onconetix Corporation
Mass-produced product of Onconetix Inc

Earnings per share (EPS TTM) measures the portion of profit allocated to each outstanding share of common stock over a trailing twelve-month period. This metric allows investors to objectively compare the efficiency of different issuers by neutralizing differences in capital. Analyzing this 12-month net income per share chart enables an assessment of the business's scaling pace. For Onconetix, Inc. (ONCO), this indicator reflects financial stability amid stringent FDA oversight. Patents for radiosensitization establish the foundation for future profit growth.

Main competitors

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai LifeSciences)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|Earnings per share for the last twelve months Cytek Biosciences Inc|Net earnings per share (EPS TTM) OraSure Corp|Net earnings per share for the last 12 months XGN (Exagen Inc)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group)|Net earnings per share for the trailing year bluejaydx.com|AWH: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Accelerate Diagnostics, Inc. AXDX|CNTG (CENTOGENE) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ENZ|FRES: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co)|PMD - Net earnings per one share for the last twelve months